(Sức khỏe & Đời sống) – STADA Pymepharco, a trusted pharmaceutical manufacturer and the sole wholly affiliate member in Vietnam of STADA Group (Germany) since 2021, recently partnered with the Vietnam Pharmaceutical Association to host a scientific symposium titled “Rational and Effective Antibiotic Use in Community-Acquired Respiratory Infections”.
The event gathered over 550 pharmacists and healthcare professionals both in person in Ho Chi Minh City and via livestream from four satellite locations nationwide: Hanoi, Thanh Hoa, Da Nang, and Gia Lai. The strong participation underscored STADA Pymepharco’s firm commitment to raising awareness and advancing the practice of rational antibiotic use.
Representatives from STADA Group and STADA Pymepharco joined guest speakers for a commemorative photo.
The symposium welcomed senior leaders from STADA Group, including Ms. Simone Berger, Chief People & Culture Officer (CPO), and Mr. Stéphane Jacqmin, Executive Vice President Emerging Markets. Their presence not only highlighted the importance of the event but also reaffirmed STADA’s long-term commitment to supporting the development of Vietnam’s healthcare and pharmaceutical sectors. The event exemplified STADA Pymepharco’s role in bridging global healthcare standards with local medical practice.
STADA and STADA Pymepharco leadership expressed appreciation to keynote speakers Assoc. Prof. Dr. Nguyen Tuan Dung (Clinical Pharmacy) and Assoc. Prof. Dr. Tran Van Ngoc (Respiratory Medicine)
Focusing on practical treatment guidelines and clinical case discussions, the symposium aimed to reinforce the pharmacist’s role in promoting appropriate antibiotic use, particularly for community-acquired respiratory infections, one of the most prevalent public health issues today. Leading experts shared in-depth, practice-oriented insights into treatment approaches, antibiotic selection, and optimizing clinical outcomes. The symposium not only updated professional knowledge but also equipped pharmacists with essential tools to respond to the growing challenge of antimicrobial resistance.
Assoc. Prof. Dr. Bui Thi Huong Quynh, Senior Lecturer in Clinical Pharmacy, HCMC University of Medicine and Pharmacy, and Vice Head of Pharmacy Department, Thong Nhat Hospital, shares practical guidance for community pharmacists on antibiotic use in treating respiratory infections.
Antimicrobial resistance is one of the greatest global health threats, particularly in developing countries like Vietnam, where antibiotic usage remains poorly regulated. The symposium emphasized that rational antibiotic use not only enhances treatment outcomes but also protects public health, reduces resistance risks, and prolongs the efficacy of existing antibiotics. The event marked a meaningful step forward in the ongoing collaboration between STADA Pymepharco and the Vietnam Pharmaceutical Association to improve pharmaceutical practices and healthcare delivery. As a committed industry leader, STADA Pymepharco will continue to organize scientific initiatives, training programs, and international partnerships to support healthcare professionals and contribute to a more sustainable, effective healthcare system in Vietnam.
Mr. Philippe Gautron, General Manager of STADA Pymepharco, shared: "This symposium marks an important milestone in our ongoing efforts to improve public health. It follows our Vietnam Health Report launched in January 2024 as part of the Global Health Report series by STADA Group. In partnership with the Vietnam Pharmaceutical Association, we are proud to contribute to building a healthier future for the Vietnamese community”.
Mr. Philippe Gautron, General Manager of STADA Pymepharco, delivers remarks.
Ms. Tran Hoang Y Yen, Commercial Head at STADA Pymepharco, added: “Events like this reinforce our long-term vision, not only to be a manufacturer and supplier of pharmaceuticals, but to be a trusted partner to Vietnam’s healthcare community”.
STADA Pymepharco (Vietnam)
Source: Báo Sức khỏe & Đời sống
